A “hand-picked” plaintiff drops her case, while Merck readies for the next round of trials – including Merck v Lanier II.
Merck/Vioxx update
More in Uncategorized
Past Week
-
Medicine’s struggle for inclusivity
-
Venture-backed telemental health care companies are creating a new opioid epidemic
-
Biotechnology and biological warfare [PODCAST]
-
AI’s role in simplifying communication [PODCAST]
-
Optimizing IUD placement: prescribed medications and timing tips
-
Preventing amputations and saving lives starts with bringing PAD into the 21st century
-
Past 6 Months
-
Medicine’s struggle for inclusivity
-
Medicine is not apolitical: Your vote dictates your ability to practice medicine
-
Venture-backed telemental health care companies are creating a new opioid epidemic
-
Elite access vs. public scrutiny: Medication disparities exposed
-
When the doctor’s office becomes a confession booth
-
Real pain deserves real treatment
-
Recent Posts
-
Biotechnology and biological warfare [PODCAST]
-
Doctors beware: Your credentials could land you in prison
-
Fulfilling fatherhood and a thriving medical practice: my story
-
Non-opioid post-op pain relief [PODCAST]
-
I had a (incorrect) memory screening. Have you even had one?
-
Why doctors should embrace uncertainty for better patient outcomes
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
